Lapatinib in advanced chordoma: A phase II study

被引：0
|
作者：
Stacchiotti, Silvia
Tamborini, Elena
Palassini, Elena
Negri, Tiziana
Marrari, Andrea
Messina, Antonella
Morosi, Carlo
De Troia, Beatrice
Longhi, Alessandra
Palmerini, Emanuela
Gronchi, Alessandro
Pilotti, Silvana
Casali, Paolo Giovanni
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Ist Ortoped Rizzoli, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10026
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer
    Chu, Quincy S. C.
    Cianfrocca, Mary E.
    Goldstein, Lori J.
    Gale, Meg
    Murray, Nicholas
    Loftiss, Jill
    Arya, Nikita
    Koch, Kevin M.
    Pandite, Lini
    Fleming, Ronald A.
    Paul, Elaine
    Rowinsky, Eric K.
    CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4484 - 4490
  • [22] A Phase I Study of Capecitabine, Oxaliplatin, and Lapatinib in Metastatic or Advanced Solid Tumors
    Dennie, Trevor W.
    Fleming, Ronald A.
    Bowen, Carolyn J.
    Dar, Mohammed M.
    Alberti, Dona
    Oliver, Katherine
    Loconte, Noelle
    Mulkerin, Dan
    Holen, Kyle D.
    CLINICAL COLORECTAL CANCER, 2011, 10 (01) : 57 - 62
  • [23] A randomized phase II study: Pazopanib (P) versus lapatinib (L) versus combination of pazopanib/lapatinib (L plus P) in advanced and recurrent cervical cancer (CC)
    Monk, B.
    Mas, L.
    Zarba, J. J.
    Oaknin, A.
    Tarpin, C.
    Termrungruanglert, W.
    Alber, J. A.
    Ding, J.
    Stutts, N. W.
    Pandite, L. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study
    Stacchiotti, Silvia
    Morosi, Carlo
    Lo Vullo, Salvatore
    Casale, Alessandra
    Palassini, Elena
    Frezza, Anna Maria
    Dinoi, Gabriella
    Messina, Antonella
    Gronchi, Alessandro
    Cavalleri, Adalberto
    Venturelli, Elisabetta
    Morelli, Daniele
    Pilotti, Silvana
    Collini, Paola
    Brich, Silvia
    Tamborini, Elena
    Mariani, Luigi
    Casali, Paolo G.
    CANCER, 2018, 124 (20) : 4056 - 4063
  • [25] A phase II study of letrozole and lapatinib followed by an addition of everolimus in postmenopausal women with advanced endocrine resistant breast cancer (BC)
    Chumsri, S.
    Tait, N.
    Shetty, J.
    Lewis, J.
    Medeiros, M.
    Bao, T.
    Goloubeva, O.
    Singh, H.
    Sivasailam, S.
    Sabnis, G.
    Kazi, A.
    Mann, D.
    Kesmodel, S.
    Brodie, A.
    Tkaczuk, K.
    CANCER RESEARCH, 2013, 73
  • [26] A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
    Massimo Cristofanilli
    Stephen R. D. Johnston
    Alexey Manikhas
    Henry L. Gomez
    Oleg Gladkov
    Zhimin Shao
    Sufia Safina
    Kimberly L. Blackwell
    Ricardo H. Alvarez
    Stephen D. Rubin
    Sulabha Ranganathan
    Suman Redhu
    Maureen E. Trudeau
    Breast Cancer Research and Treatment, 2013, 137 : 471 - 482
  • [27] Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies
    Chu, Quincy S. C.
    Schwartz, Garry
    de Bono, Johann
    Smith, Deborah A.
    Koch, Kevin M.
    Versola, Melissa J.
    Pandite, Lini
    Arya, Nikita
    Curtright, Jan
    Fleming, Ronald A.
    Ho, Peter T. C.
    Rowinsky, Eric K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3753 - 3758
  • [28] Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies
    A R Tan
    A Dowlati
    M N Stein
    S F Jones
    J R Infante
    J Bendell
    M P Kane
    K T Levinson
    A B Suttle
    H A Burris III
    British Journal of Cancer, 2014, 110 : 2647 - 2654
  • [29] Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies
    Tan, A. R.
    Dowlati, A.
    Stein, M. N.
    Jones, S. F.
    Infante, J. R.
    Bendell, J.
    Kane, M. P.
    Levinson, K. T.
    Suttle, A. B.
    Burris, H. A., III
    BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2647 - 2654
  • [30] Survival Data From a Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy in Patients With Advanced and Recurrent Cervical Cancer
    Monk, Bradley J.
    Pandite, Lini N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (36) : 4845 - 4845
12345